The aim of the study is to asses the hydration status of incident peritoneal dialysis (PD) patients and its evolution over a period of four years, independent of the PD treatment modality (APD or CAPD) and the PD solution type.
Achieving optimal fluid balance remains a major clinical challenge in peritoneal dialysis (PD) patients. With the recent development of a new bioimpedance spectroscopy (BIS) device, the BCM-Body Composition Monitor (BCM), it is now possible to quantify deviations of hydration status and to define target weight directly. It has been observed that more than 50% of the PD patients are overhydrated, as compared to the healthy population. This overhydration seems to be associated with modifiable practice-related factors, such as correct PD prescription according to membrane transport status, and dietary fluid intake. The aim of this study is to assess the hydration status of incident PD patients, and diagnose the underlying reasons for incorrect fluid status. In addition, changes in fluid status, residual renal function and nutritional status, over a follow-up period of up to four years will be registered. The investigators assume that the use of the BCM-Body Composition Monitor (BCM) provides quantitative measurement of hydration status and thereby supports physicians in identifying patients who are not euvolaemic. Hence, the BCM allows an improved management of underlying causes of non-euvolaemic hydration state and appropriate monitoring of fluid status.
Study Type
OBSERVATIONAL
Enrollment
1,092
This is a purely non-interventional, observational study, where treatment decisions are completely guided by the discretion of the attending nephrologists.
Hydration status
Assessed via body composition measurements (Overhydration, total body water (TBW), extracellular water (ECW), intracellular water (ICW)) (Overhydration, total body water (TBW), extracellular water (ECW), intracellular water (ICW))
Time frame: Every three months over a period of four years
Residual renal function
Time frame: Every three months over a period of four years
Peritoneal transport status
Time frame: Every three months over a period of four years
Time to change to haemodialysis
Time frame: Four years
Changes in PD prescription
Time frame: Four years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Klinikum Wels
Wels, Austria
ASZ Aalst
Aalst, Belgium
ASZ Geraardsbergen
Geraardsbergen, Belgium
Ghent University Hospital
Ghent, Belgium
U.Z. Leuven
Leuven, Belgium
CHU Sart Tilman
Liège, Belgium
Heilig-Hart Roeselare
Roeselare, Belgium
KBC Mostar
Mostar, Bosnia and Herzegovina
UKC Tuzla
Tuzla, Bosnia and Herzegovina
Instituto Mineiro Nefrologia
Belo Horizonte, Brazil
...and 124 more locations